No Posts
SKN | China Approves Pfizer GLP-1 Weight Loss Drug as Obesity Treatment Market Expands
Pfizer has received regulatory approval in China for its GLP-1 receptor agonist drug Xianweiying, marking
- sagi habasov
- •
- 4 Min Read
- •
- 3 months ago
No Posts
Pfizer has received regulatory approval in China for its GLP-1 receptor agonist drug Xianweiying, marking